Evaluation of Neoplasia With Artificial Intelligence in Gastrointestinal Endoscopy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPortsmouth Hospitals NHS Trust

About this trial

This study aims to validate and evaluate AI algorithms for detection and characterization of early GI neoplasia.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male or Female, aged 18 years or above.

Requiring gastroscopy and/or colonoscopy to investigate gastrointestinal symptoms, or as part of screening or ongoing surveillance of GI neoplasia.

Participant is willing and able to give informed consent for participation in the study.

Disqualifiers

Patients with endoscopically active severe oesophagitis

Poor bowel preparation

Trial population

In phase (1), all previously collected, anonymized and stored endoscopic images and videos of early GI neoplasia in the departmental endoscopy teaching and training library. In phase (2), all eligible patients coming for upper and/or lower GI endoscopy for clinical reasons in participating centres will be approached for enrolment into this study.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • collection of endoscopic images and videos

    Other intervention

    collection of endoscopic images and videos

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

neoplasia detection rate

neoplasia detection rate of the AI algorithms in different locations of the GI tract.

Time frame
during the procedure, up to 24 weeks, at 1 year, through study completion

Secondary outcomes

1

Accuracy of AI diagnosis

Accuracy of real time optical diagnosis (characterization) of GI neoplasia by the AI algorithm.

Time frame
during the procedure, up to 24 weeks, at 1 year, through study completion
2

Endoscopist neoplasia detection rate

Detection rate of endoscopists at various levels of experience

Time frame
during the procedure, up to 24 weeks, at 1 year, through study completion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.